(Total Views: 74)
Posted On: 09/18/2023 10:30:47 AM
Post# of 85722
$HUGE News Article - FSD Pharma announces Interim Results from First-in-Human Clinical Trial of Lucid-MS (Lucid-21-302) for Multiple Sclerosis; The Report Shows Compound to be Safe and Well Tolerated https://marketwirenews.com/news-releases/fsd-...63530.html
(0)
(0)
My Twitter: WhyteStocks
